Published in Proteomics on September 01, 2008
Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system. Microbiol Mol Biol Rev (2012) 1.11
Targeting survivin in cancer: novel drug development approaches. BioDrugs (2014) 0.98
The microRNA bantam regulates a developmental transition in epithelial cells that restricts sensory dendrite growth. Development (2014) 0.85
Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth. J Cancer Res Clin Oncol (2012) 0.82
Techniques for the Analysis of Protein-Protein Interactions in Vivo. Plant Physiol (2016) 0.82
Inhibitory activities of short linear motifs underlie Hox interactome specificity in vivo. Elife (2015) 0.79
Bioluminescence resonance energy transfer system for measuring dynamic protein-protein interactions in bacteria. MBio (2014) 0.78
Screening for novel small molecule inhibitors targeting the assembling of influenza virus polymerase complex by a BiLC-based reporter system. J Virol (2016) 0.75
Genetic interactions between UNC-17/VAChT and a novel transmembrane protein in Caenorhabditis elegans. Genetics (2012) 0.75
AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics (2007) 3.02
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine (2003) 2.00
Amyloid-like properties of bacterial inclusion bodies. J Mol Biol (2005) 1.90
Advanced glycation end product recognition by the receptor for AGEs. Structure (2011) 1.84
Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact (2005) 1.79
Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol (2007) 1.74
PRMT7, a new protein arginine methyltransferase that synthesizes symmetric dimethylarginine. J Biol Chem (2004) 1.63
Glycerol-3-phosphate dehydrogenase 2 is a novel factor H-, factor H-like protein 1-, and plasminogen-binding surface protein of Candida albicans. J Infect Dis (2012) 1.58
FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. Biochem Biophys Res Commun (2006) 1.54
Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem (2008) 1.51
Nna1-like proteins are active metallocarboxypeptidases of a new and diverse M14 subfamily. FASEB J (2007) 1.41
Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct Biol (2005) 1.34
Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease. J Am Chem Soc (2009) 1.32
Malaria reemergence in northern Afghanistan. Emerg Infect Dis (2007) 1.30
Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities. FEBS J (2006) 1.29
Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc Natl Acad Sci U S A (2005) 1.25
Amyloids in bacterial inclusion bodies. Trends Biochem Sci (2009) 1.24
Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim Biophys Acta (2008) 1.24
Mineralization of the metre-long biosilica structures of glass sponges is templated on hydroxylated collagen. Nat Chem (2010) 1.22
Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome. Angew Chem Int Ed Engl (2014) 1.21
Protein aggregation: mechanisms and functional consequences. Int J Biochem Cell Biol (2012) 1.20
Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. Eur J Biochem (2002) 1.18
Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem Biophys Res Commun (2007) 1.15
Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor. Cell Signal (2010) 1.15
Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Virol J (2007) 1.15
Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates. J Med Chem (2005) 1.13
Application of electron transfer dissociation mass spectrometry in analyses of non-enzymatically glycated peptides. Rapid Commun Mass Spectrom (2007) 1.13
Recent structural and computational insights into conformational diseases. Curr Med Chem (2008) 1.12
Automated deconvolution and deisotoping of electrospray mass spectra. J Mass Spectrom (2002) 1.11
Prion and non-prion amyloids of the HET-s prion forming domain. J Mol Biol (2007) 1.11
Development of novel antibacterial peptides that kill resistant isolates. Peptides (2002) 1.10
Protein folding and aggregation in bacteria. Cell Mol Life Sci (2010) 1.10
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol (2011) 1.09
Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem Sci (2006) 1.07
Amyloid fibril formation by a partially structured intermediate state of alpha-chymotrypsin. J Mol Biol (2004) 1.06
Fragmentation behavior of glycated peptides derived from D-glucose, D-fructose and D-ribose in tandem mass spectrometry. J Mass Spectrom (2006) 1.06
Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo. Protein Sci (2008) 1.05
Effect of temperature on protein quality in bacterial inclusion bodies. FEBS Lett (2006) 1.05
Enzymatic cyclization of a potent bowman-birk protease inhibitor, sunflower trypsin inhibitor-1, and solution structure of an acyclic precursor peptide. J Biol Chem (2003) 1.04
Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug-resistant Gram-negative pathogens. ACS Chem Biol (2012) 1.04
Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry (2006) 1.03
Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J Biotechnol (2006) 1.02
The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry (2014) 1.02
Detection of transient protein-protein interactions by bimolecular fluorescence complementation: the Abl-SH3 case. Proteomics (2007) 1.02
Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R). J Immunol (2004) 1.02
The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family. J Biol Chem (2002) 1.02
AGGRESCAN: method, application, and perspectives for drug design. Methods Mol Biol (2012) 1.01
Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin. Antimicrob Agents Chemother (2012) 1.01
Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states. Chembiochem (2011) 1.01
Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria. Amino Acids (2014) 1.01
Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J (2011) 1.01
Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies. Mass Spectrom Rev (2013) 1.01
Spectroscopic and molecular characterization of the oligomeric antenna of the diatom Phaeodactylum tricornutum. Biochemistry (2007) 1.01
Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. J Med Chem (2010) 1.01
Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex. Chembiochem (2011) 1.00
Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes. Biotechnol J (2011) 0.99
Ion mobility separation of isomeric phosphopeptides from a protein with variant modification of adjacent residues. Anal Chem (2011) 0.99
Bartonella: emerging pathogen or emerging awareness? Int J Infect Dis (2008) 0.99
Separation of multiphosphorylated peptide isomers by hydrophilic interaction chromatography on an aminopropyl phase. Anal Chem (2010) 0.98
Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus. Mol Immunol (2006) 0.98
Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects. BMC Cancer (2011) 0.97
Crystal structure of hexokinase KlHxk1 of Kluyveromyces lactis: a molecular basis for understanding the control of yeast hexokinase functions via covalent modification and oligomerization. J Biol Chem (2010) 0.97
Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Rev Anti Infect Ther (2010) 0.96
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients. Cancer Res (2006) 0.96
Study and selection of in vivo protein interactions by coupling bimolecular fluorescence complementation and flow cytometry. Nat Protoc (2008) 0.96
Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains. BMC Genomics (2013) 0.95
Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion. Microb Cell Fact (2009) 0.95
The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells. Microb Cell Fact (2006) 0.95
Structural studies on the forward and reverse binding modes of peptides to the chaperone DnaK. J Mol Biol (2013) 0.94
Internalization of cystatin C in human cell lines. FEBS J (2008) 0.94
Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice. PLoS One (2011) 0.94
Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases. PLoS Comput Biol (2009) 0.94
Sulfated polysaccharides promote the assembly of amyloid beta(1-42) peptide into stable fibrils of reduced cytotoxicity. J Biol Chem (2008) 0.93
Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin Immunol (2005) 0.93
Identification and relative quantification of specific glycation sites in human serum albumin. Anal Bioanal Chem (2010) 0.93
The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models. Int J Antimicrob Agents (2009) 0.93
Detecting remotely related proteins by their interactions and sequence similarity. Proc Natl Acad Sci U S A (2005) 0.93
Ile-phe dipeptide self-assembly: clues to amyloid formation. Biophys J (2006) 0.93
Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation. Mol Biosyst (2012) 0.92
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb Cell Fact (2012) 0.92
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres. Eur J Nucl Med Mol Imaging (2011) 0.92
New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA. Inorg Chem (2005) 0.92
Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure. FASEB J (2010) 0.91
Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics. Peptides (2008) 0.91
Surface supercharged human enteropeptidase light chain shows improved solubility and refolding yield. Protein Eng Des Sel (2010) 0.91
Identification of cysteine, methionine and tryptophan residues of actin oxidized in vivo during oxidative stress. J Proteome Res (2010) 0.91
Easy strategy to protect antimicrobial peptides from fast degradation in serum. Antimicrob Agents Chemother (2010) 0.91
Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation. Biopolymers (2011) 0.90
Prediction of enzyme function by combining sequence similarity and protein interactions. BMC Bioinformatics (2008) 0.90
Protein aggregation profile of the bacterial cytosol. PLoS One (2010) 0.90
In vitro and in vivo activity of an antibacterial peptide analog against uropathogens. Peptides (2003) 0.90